Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.
Taskinen MR, Björnson E, Matikainen N, Söderlund S, Rämö J, Ainola MM, Hakkarainen A, Sihlbom C, Thorsell A, Andersson L, Bergh PO, Henricsson M, Romeo S, Adiels M, Ripatti S, Laakso M, Packard CJ, Borén J. Taskinen MR, et al. Among authors: thorsell a. JCI Insight. 2022 Oct 10;7(19):e160607. doi: 10.1172/jci.insight.160607. JCI Insight. 2022. PMID: 36040803 Free PMC article. Clinical Trial.
Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E, Packard CJ, Adiels M, Andersson L, Matikainen N, Söderlund S, Kahri J, Hakkarainen A, Lundbom N, Lundbom J, Sihlbom C, Thorsell A, Zhou H, Taskinen MR, Borén J. Björnson E, et al. Among authors: thorsell a. J Intern Med. 2020 Oct;288(4):422-438. doi: 10.1111/joim.13017. Epub 2020 Jan 7. J Intern Med. 2020. PMID: 31846520 Free article.
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Taskinen MR, Björnson E, Kahri J, Söderlund S, Matikainen N, Porthan K, Ainola M, Hakkarainen A, Lundbom N, Fermanelli V, Fuchs J, Thorsell A, Kronenberg F, Andersson L, Adiels M, Packard CJ, Borén J. Taskinen MR, et al. Among authors: thorsell a. Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):962-975. doi: 10.1161/ATVBAHA.120.315446. Epub 2020 Dec 24. Arterioscler Thromb Vasc Biol. 2021. PMID: 33356392 Free article.
Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.
Taskinen MR, Björnson E, Matikainen N, Söderlund S, Pietiläinen KH, Ainola M, Hakkarainen A, Lundbom N, Fuchs J, Thorsell A, Andersson L, Adiels M, Packard CJ, Borén J. Taskinen MR, et al. Among authors: thorsell a. Diabetes Obes Metab. 2021 May;23(5):1191-1201. doi: 10.1111/dom.14328. Epub 2021 Mar 5. Diabetes Obes Metab. 2021. PMID: 33502078
Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism.
Taskinen MR, Matikainen N, Björnson E, Söderlund S, Ainola M, Hakkarainen A, Lundbom N, Sihlbom C, Thorsell A, Andersson L, Adiels M, Hartmann B, Deacon CF, Holst JJ, Packard CJ, Borén J. Taskinen MR, et al. Among authors: thorsell a. Eur J Endocrinol. 2022 May 19;187(1):75-84. doi: 10.1530/EJE-21-1187. Eur J Endocrinol. 2022. PMID: 35521766
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia.
Adiels M, Taskinen MR, Björnson E, Andersson L, Matikainen N, Söderlund S, Kahri J, Hakkarainen A, Lundbom N, Sihlbom C, Thorsell A, Zhou H, Pietiläinen KH, Packard C, Borén J. Adiels M, et al. Among authors: thorsell a. Diabetes Obes Metab. 2019 Aug;21(8):1861-1870. doi: 10.1111/dom.13744. Epub 2019 May 8. Diabetes Obes Metab. 2019. PMID: 30972934 Clinical Trial.
147 results